This FLT3 inhibitor, Gilteritinib, is meant for people with AML, especially those who’ve had a tough time and have FLT3 mutations. It’s made to stop the FLT3 kinase from doing its thing, which helps shrink those leukemia cells. You can get this drug in 40 mg tablet form, with a film coating on ’em.
They usually suggest taking 120 mg of this stuff, once a day, by mouth. Each bottle’s got 90 tablets in it, making it easy and consistent for taking the treatment.